HIGHLIGHTS
- who: September and collaborators from the School of Traditional Chinese Medicine, Capital Medical University, China have published the Article: Cardiovascular safety of febuxostat and allopurinol in patients with gout: A meta-analysis, in the Journal: (JOURNAL) of 30/01/2022
- what: In this meta-analysis, the authors focused on time-event data which evaluated the cardiovascular safety of febuxostat and allopurinol using reconstructed individual-patient data.
- how: The curve fitting results are shown in Figure 2. To compare the cardiovascular safety of febuxostat and allopurinol in patients with gout the authors conducted 1 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.